Is Pharma (LON:ISPH) - Profitability in sight

Wednesday, Jun 06 2007 by

Jun 06th 2007 - Edison Investment Research today published a report on Is Pharma (ISPH.L, LSE:ISPH, LON:ISPH) entitled "Profitability In Sight". In summary, the report says:

Following the recent £13m takeover of Acorus Therapeutics, the new Maelor is set to hit profitability in fiscal 2008, driven by the acquired product portfolio. It has just published 2007 results which relate to the former Maelor business.

About Edison Investment Research

Edison Investment Research


Edison Investment Research is a leading international investment research company. It has won industry recognition, with awards both in the UK and internationally. The team of 95 includes over 60 analysts supported by a department of supervisory analysts, editors and assistants. Edison writes on more than 400 companies across every sector and works directly with corporates, fund managers, investment banks, brokers and other advisers. Edison’s research is read by institutional investors, alternative funds and wealth managers in more than 100 countries. Edison, founded in 2003, has offices in London, New York and Sydney and is authorised and regulated by the Financial Services Authority ( more »